Page 86 - Human Umbilical Cord Mesenchymal Stem Cells
P. 86

1486                                                                               R. Friedman et al.



                differentiation capacity and in vivo bone formation in calcium  36. Li Q, Hisha H, Yasumizu R, et al. Analysis of very early hema-
                phosphate ceramics. Platelets. 2006;7:462-469.    topoietic regeneration after bone marrow transplantation: com-
             31. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of  parison of intravenous and intrabone marrow routes. Stem Cells.
                two partially HLA-matched umbilical cord blood units to en-  2007;25:1186-1194.
                hance engraftment in adults with hematologic malignancy.  37. Mazurier F, Doedens M, Gan OI, et al. Rapid myeloerythroid
                Blood. 2005;105:1343-1347.                        repopulation after intrafemoral transplantation of NOD-SCID
             32. Angelopoulou M, Novelli E, Grove JE, et al. Co-transplantation  mice reveals a new class of human stem cells. Nat Med. 2003;9:
                of human mesenchymal stem cells enhances human myelopoie-  959-963.
                sis and megakaryocytopoiesis in NOD/SCID mice. Exp Hema-  38. Tuncer HT, Betancur M, Boissel L, et al. Ex-vivo expansion
                tol. 2003;31:413-420.                             and mRNA transfection of cord blood–derived natural killer
             33. Robinson SN, Ng J, Yang H, et al. Superior ex vivo cord blood  cells with preserved cytotoxicity [abstract]. Blood. 2006;108:
                expansion following co-culture with bone marrow–derived mes-  1045a.
                enchymal cells. Bone Marrow Transplant. 2006;37:359-366.  39. Chapel A, Bertho JM, Bensidhoum M, et al. Mesenchymal stem
             34. Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic  cells home to injured tissues when co-infused with hematopoi-
                  ¸
                recovery after co-infusion of autologous blood stem cells and  etic cells to treat a radiation-induced multi-organ failure syn-
                culture-expanded marrow mesenchymal stem cells in advanced  drome. J Gene Med. 2003;5:1028-1038.
                breast cancer patients receiving high-dose chemotherapy. J  40. Studeny M, Marini FC, Champlin RE, et al. Bone marrow–
                Clin Oncol. 2000;18:307-316.                      derived mesenchymal stem cells as vehicles for interferon-ß de-
             35. Lazarus HM, Koc ON, Devine SM. Co-transplantation of  livery into tumors. Cancer Res. 2002;62:3603-3608.
                HLA-identical sibling culture-expanded mesenchymal stem  41. Stagg J, Lejeune L, Paquin A, et al. Marrow stromal cells for in-
                cells and hematopoietic stem cells in hematologic malignancy  terleukin-2 delivery in cancer immunotherapy. Hum Gene Ther.
                patients. Biol Blood Marrow Transplant. 2005;11:389-398.  2004;15:597-608.
   81   82   83   84   85   86   87   88   89   90   91